Kangyu Wang

Lanzhou University

Papers

3

Total Citations

10

H-Index

2

About

Dr. Kangyu Wang is a rising leader in urologic oncology, with a focused expertise in robotic-assisted surgery for prostate and kidney cancers. His major contributions center on refining surgical techniques to improve patient outcomes, particularly through comparative effectiveness research. Dr. Wang’s landmark meta-analysis on Retzius-sparing robot-assisted radical prostatectomy (2025, 5 citations) provides critical evidence that this approach offers superior functional recovery—such as early continence—compared to conventional methods, without compromising oncologic control. He has also pioneered investigations into single-port robotic partial nephrectomy for obese patients (2025, 3 citations), demonstrating that this minimally invasive approach reduces perioperative complications and preserves renal function. Additionally, his work comparing the Da Vinci and Hinotori surgical systems (2025, 2 citations) offers early, valuable insights into the performance of next-generation robotic platforms in urologic tumor surgery. Though early in his career, Dr. Wang’s rapid accumulation of citations and his focus on high-impact, evidence-based surgical innovation mark him as a promising authority in advancing precision, patient-centered urologic care.

Research Focus

Key Achievements

2
H-Index
3
Papers
10
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Perioperative and functional outcomes of Retzius-sparing robot-assisted radical prostatectomy vs. conventional robot-assisted radical prostatectomy: evidence based on randomized-controlled trials
5 citations · 2025
📈 Most Prolific Year: 2025 (3 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Lanzhou University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago